TargetMol

Proquazone

Product Code:
 
TAR-T28454
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T28454-1mg1mg£175.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28454-1mL1 mL * 10 mM (in DMSO)£250.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28454-5mg5mg£286.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28454-10mg10mg£351.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28454-25mg25mg£544.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28454-50mg50mg£747.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28454-100mg100mg£1,002.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28454-500mg500mg£1,942.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Proquazone is a nonsteroidal anti-inflammatory agent.
CAS:
22760-18-5
Formula:
C18H18N2O
Molecular Weight:
278.355
Purity:
0.98
SMILES:
CC(C)n1c2cc(C)ccc2c(nc1=O)-c1ccccc1

References

1. M?k?r?inen L, Ylikorkala O. Menstrual blood loss in dysmenorrhoea: effects of proquazone and indomethacin. Br J Obstet Gynaecol. 1983 Jun;90(6):570-2. 2. von Orelli J, Leuenberger H. Search for technological reasons to develop a capsule or a tablet formulation with respect to wettability and dissolution. Int J Pharm. 2004 Dec 9;287(1-2):135-45. 3. Roos A, Hinderling PH. Protein binding and erythrocyte partitioning of the antirheumatic proquazone. J Pharm Sci. 1981 Mar;70(3):252-7. 4. Ohnhaus EE. The effect of antacid and food on the absorption of proquazone (Biarison) in man. Int J Clin Pharmacol Ther Toxicol. 1980 Mar;18(3):136-9.